EPRX
Price
$5.39
Change
+$0.03 (+0.56%)
Updated
Sep 5 closing price
Capitalization
192.12M
60 days until earnings call
ETNB
Price
$8.87
Change
+$0.26 (+3.02%)
Updated
Sep 5 closing price
Capitalization
1.32B
61 days until earnings call
Interact to see
Advertisement

EPRX vs ETNB

Header iconEPRX vs ETNB Comparison
Open Charts EPRX vs ETNBBanner chart's image
Eupraxia Pharmaceuticals
Price$5.39
Change+$0.03 (+0.56%)
Volume$30.3K
Capitalization192.12M
89bio
Price$8.87
Change+$0.26 (+3.02%)
Volume$1.93M
Capitalization1.32B
EPRX vs ETNB Comparison Chart in %
Loading...
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EPRX vs. ETNB commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EPRX is a Hold and ETNB is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (EPRX: $5.39 vs. ETNB: $8.87)
Brand notoriety: EPRX and ETNB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EPRX: 261% vs. ETNB: 131%
Market capitalization -- EPRX: $192.12M vs. ETNB: $1.32B
EPRX [@Biotechnology] is valued at $192.12M. ETNB’s [@Biotechnology] market capitalization is $1.32B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EPRX’s FA Score shows that 0 FA rating(s) are green whileETNB’s FA Score has 1 green FA rating(s).

  • EPRX’s FA Score: 0 green, 5 red.
  • ETNB’s FA Score: 1 green, 4 red.
According to our system of comparison, ETNB is a better buy in the long-term than EPRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EPRX’s TA Score shows that 5 TA indicator(s) are bullish while ETNB’s TA Score has 3 bullish TA indicator(s).

  • EPRX’s TA Score: 5 bullish, 4 bearish.
  • ETNB’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, EPRX is a better buy in the short-term than ETNB.

Price Growth

EPRX (@Biotechnology) experienced а +0.56% price change this week, while ETNB (@Biotechnology) price change was -1.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

EPRX is expected to report earnings on Nov 05, 2025.

ETNB is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ETNB($1.32B) has a higher market cap than EPRX($192M). EPRX YTD gains are higher at: 70.032 vs. ETNB (13.427). EPRX has higher annual earnings (EBITDA): -28.83M vs. ETNB (-442.86M). ETNB has more cash in the bank: 561M vs. EPRX (19.8M). EPRX has less debt than ETNB: EPRX (35.1K) vs ETNB (37.6M). EPRX (0) and ETNB (0) have equivalent revenues.
EPRXETNBEPRX / ETNB
Capitalization192M1.32B15%
EBITDA-28.83M-442.86M7%
Gain YTD70.03213.427522%
P/E RatioN/AN/A-
Revenue00-
Total Cash19.8M561M4%
Total Debt35.1K37.6M0%
FUNDAMENTALS RATINGS
ETNB: Fundamental Ratings
ETNB
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EPRXETNB
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
55%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
43%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
42%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend about 1 month ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
38%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COIHY16.590.29
+1.78%
Croda International Plc
SZKMY54.580.32
+0.59%
Suzuki Motor Co.
FNNNF3.75N/A
N/A
Finnair OYJ
XXMMF0.07N/A
N/A
XIMEN MINING CORP
MRMD0.16-0.01
-8.53%
MariMed Inc.

EPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EPRX has been loosely correlated with NAGE. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if EPRX jumps, then NAGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EPRX
1D Price
Change %
EPRX100%
+0.56%
NAGE - EPRX
34%
Loosely correlated
+0.97%
IVEVF - EPRX
28%
Poorly correlated
N/A
ACAD - EPRX
28%
Poorly correlated
-0.94%
ETNB - EPRX
26%
Poorly correlated
+3.02%
MDGL - EPRX
26%
Poorly correlated
+0.39%
More

ETNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETNB has been loosely correlated with AKRO. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ETNB jumps, then AKRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETNB
1D Price
Change %
ETNB100%
+3.02%
AKRO - ETNB
60%
Loosely correlated
+1.57%
IDYA - ETNB
54%
Loosely correlated
+5.15%
IRON - ETNB
50%
Loosely correlated
+0.95%
BEAM - ETNB
49%
Loosely correlated
+12.62%
CRNX - ETNB
49%
Loosely correlated
+3.97%
More